Task: Answer the multiple choice question.
Query: Which drug exhibits a -19.879% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: COc1ccc(C2/C=C\CN(Cc3ccncc3)CC(=O)N2Cc2ccc(F)cc2)cc1
b: CCC12CC3CC(C1)CC(C(=O)Nc1nn[nH]n1)(C3)C2
Answer: b. CCC12CC3CC(C1)CC(C(=O)Nc1nn[nH]n1)(C3)C2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC12CC3CC(C1)CC(C(=O)Nc1nn[nH]n1)(C3)C2
CCC12CC3CC(C1)CC(C(=O)Nc1nn[nH]n1)(C3)C2
3-ethyl-N-(2H-tetrazol-5-yl)adamantane-1-carboxamide